NACDS Foundation launches accessible TB treatment and prevention study in New Mexico
The NACDS Foundation announced Thursday the launch of a research initiative examining the impact of expanded access to community testing for latent tuberculosis infections.
The NACDS Foundation announced Thursday the launch of a research initiative examining the impact of expanded access to community testing for latent tuberculosis infections. The aim of the study, led by researchers at the University of New Mexico, is to understand the health care experience of those receiving TB testing in a community pharmacy setting and evaluate improved patient health outcomes and access to care. Patients seeking care will be counseled by trained pharmacists on TB risk factors and prevention. Those testing positive for TB will be referred to the New Mexico Department of Health Tuberculosis Program for a no-cost, 12-week medication regimen and education plan. The study will also evaluate the ability of the training program developed by CDC to increase screening and treatment adherence. Seven community pharmacies in Albuquerque and Santa Fe have confirmed their participation in the study, which will conclude in September 2017. More than 100 patients who previously received a TB test in a pharmacy have consented to participate so far.